Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Mol Cell Proteomics ; 19(9): 1418-1435, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32518069

RESUMO

Synaptic transmission leading to release of neurotransmitters in the nervous system is a fast and highly dynamic process. Previously, protein interaction and phosphorylation have been thought to be the main regulators of synaptic transmission. Here we show that sialylation of N-linked glycosylation is a novel potential modulator of neurotransmitter release mechanisms by investigating depolarization-dependent changes of formerly sialylated N-linked glycopeptides. We suggest that negatively charged sialic acids can be modulated, similarly to phosphorylation, by the action of sialyltransferases and sialidases thereby changing local structure and function of membrane glycoproteins. We characterized site-specific alteration in sialylation on N-linked glycoproteins in isolated rat nerve terminals after brief depolarization using quantitative sialiomics. We identified 1965 formerly sialylated N-linked glycosites in synaptic proteins and found that the abundances of 430 glycosites changed after 5 s depolarization. We observed changes on essential synaptic proteins such as synaptic vesicle proteins, ion channels and transporters, neurotransmitter receptors and cell adhesion molecules. This study is to our knowledge the first to describe ultra-fast site-specific modulation of the sialiome after brief stimulation of a biological system.


Assuntos
Glicoproteínas de Membrana/metabolismo , Neurotransmissores/metabolismo , Nervos Periféricos/metabolismo , Proteoma/metabolismo , Ácidos Siálicos/metabolismo , Sinapses/metabolismo , Membranas Sinápticas/metabolismo , Animais , Cloratos/farmacologia , Cromatografia Líquida , Glicosídeos/metabolismo , Glicosilação , Masculino , Glicoproteínas de Membrana/química , Nervos Periféricos/enzimologia , Nervos Periféricos/fisiologia , Proteoma/química , Proteoma/efeitos dos fármacos , Proteoma/fisiologia , Proteômica , Ratos , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/química , Ácidos Siálicos/química , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Sinapses/química , Sinapses/efeitos dos fármacos , Sinapses/fisiologia , Membranas Sinápticas/efeitos dos fármacos , Membranas Sinápticas/enzimologia , Espectrometria de Massas em Tandem
2.
Expert Rev Proteomics ; 15(3): 245-258, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29376447

RESUMO

INTRODUCTION: Exploring post-translational modifications (PTMs) with the use of mass spectrometry (PTMomics) is a rapidly developing area, with methods for discovery/quantification being developed and advanced on a regular basis. PTMs are highly important for the regulation of protein function, interaction and activity, both in physiological and disease states. Changes in PTMs can either cause, or be the result of a disease, making them central for biomarker studies and studies of disease pathogenesis. Recently, it became possible to study multiple PTMs simultaneously from low amount of sample material, thereby increasing coverage of the PTMome obtainable from a single sample. Thus, quantitative PTMomics holds great potential to discover biomarkers from tissue and body fluids as well as elucidating disease mechanisms through characterization of signaling pathways. Areas covered: Recent mass spectrometry-based methods for assessment of the PTMome, with focus on the most studied PTMs, are highlighted. Furthermore, both data dependent and data independent acquisition methods are evaluated. Finally, current challenges in the field are discussed. Expert commentary: PTMomics holds great potential for clinical and biomedical research, especially with the generation of spectral libraries of peptides and PTMs from individual patients (permanent PTM maps) for use in personalized medicine.


Assuntos
Biomarcadores/metabolismo , Espectrometria de Massas/métodos , Processamento de Proteína Pós-Traducional , Proteoma/metabolismo , Proteômica/métodos , Animais , Biomarcadores/química , Humanos , Proteoma/química
3.
Cells ; 9(5)2020 05 24.
Artigo em Inglês | MEDLINE | ID: mdl-32456348

RESUMO

Interleukin-6 (IL-6) signaling is a crucial regulatory event important for many biological functions, such as inflammation and tissue regeneration. Accordingly, several pathological conditions are associated with dysregulated IL-6 activity, making it an attractive therapeutic target. For instance, blockade of IL-6 or its α-receptor (IL-6R) by monoclonal antibodies has been successfully used to treat rheumatoid arthritis. However, based on different signaling modes, IL-6 function varies between pro- and anti-inflammatory activity, which is critical for therapeutic intervention. So far, three modes of IL-6 signaling have been described, the classic anti-inflammatory signaling, as well as pro-inflammatory trans-signaling, and trans-presentation. The IL-6/IL-6R complex requires an additional ß-receptor (gp130), which is expressed on almost all cells of the human body, to induce STAT3 (signal transducer and activator of signal transcription 3) phosphorylation and subsequent transcriptional regulation. In contrast, the IL-6R is expressed on a limited number of cells, including hepatocytes and immune cells. However, the proteolytic release of the IL-6R enables trans-signaling on cells expressing gp130 only. Here, we demonstrate a fourth possibility of IL-6 signaling that we termed joint reconstituted signaling (JRS). We show that IL-6R on extracellular vesicles (EVs) can also be transported to and fused with other cells that lack the IL-6R on their surface. Importantly, JRS via EVs induces delayed STAT3 phosphorylation compared to the well-established trans-signaling mode. EVs isolated from human serum were already shown to carry the IL-6R, and thus this new signaling mode should be considered with regard to signal intervention.


Assuntos
Vesículas Extracelulares/metabolismo , Receptores de Interleucina-6/metabolismo , Transdução de Sinais , Membrana Celular/metabolismo , Sobrevivência Celular , Vesículas Extracelulares/ultraestrutura , Células HEK293 , Humanos , Modelos Biológicos , Fosforilação , Fator de Transcrição STAT3/metabolismo
4.
Sci Rep ; 7: 44053, 2017 03 09.
Artigo em Inglês | MEDLINE | ID: mdl-28276471

RESUMO

Soluble Interleukin-6 receptor (sIL-6R) mediated trans-signaling is an important pro-inflammatory stimulus associated with pathological conditions, such as arthritis, neurodegeneration and inflammatory bowel disease. The sIL-6R is generated proteolytically from its membrane bound form and A Disintegrin And Metalloprotease (ADAM) 10 and 17 were shown to perform ectodomain shedding of the receptor in vitro and in vivo. However, under certain conditions not all sIL-6R could be assigned to ADAM10/17 activity. Here, we demonstrate that the IL-6R is a shedding substrate of soluble meprin α and membrane bound meprin ß, resulting in bioactive sIL-6R that is capable of inducing IL-6 trans-signaling. We determined cleavage within the N-terminal part of the IL-6R stalk region, distinct from the cleavage site reported for ADAM10/17. Interestingly, meprin ß can be shed from the cell surface by ADAM10/17 and the observation that soluble meprin ß is not capable of shedding the IL-6R suggests a regulatory mechanism towards trans-signaling. Additionally, we observed a significant negative correlation of meprin ß expression and IL-6R levels on human granulocytes, providing evidence for in vivo function of this proteolytic interaction.


Assuntos
Metaloendopeptidases/metabolismo , Receptores de Interleucina-6/metabolismo , Transdução de Sinais , Proteína ADAM10/genética , Proteína ADAM10/metabolismo , Proteína ADAM17/genética , Proteína ADAM17/metabolismo , Secretases da Proteína Precursora do Amiloide/genética , Secretases da Proteína Precursora do Amiloide/metabolismo , Células HEK293 , Humanos , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Metaloendopeptidases/genética , Receptores de Interleucina-6/genética , Solubilidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA